There is widespread agreement that the only way to safely reopen the economy is through a massive increase in testing. Tests for mass screening may have different requirements and characteristics from the tests run in clinical labs today that are approved by the Food and Drug Administration. So what might a solution look like?
Publisher: MIT Technology Review | Author: Sri Kosuri